Mira Keyes, MD FRCPC

Clinical Professor
Active Staff: BC Cancer Agency – Vancouver Centre and Vancouver General Hospital

City: Vancouver
Hospital Authority: Provincial Health Services

600 West 10th Avenue
Vancouver, BC V5Z 4E6

Phone: 604.877.6000 local 2660     Fax: 604.877.0505

Email: mkeyes@bccancer.bc.ca

Major Clinical Focus:
• Prostate Brachytherapy
• Genito-Urinary Oncology
• Breast Cancer
• Postgraduate Medical Education
• Patient Communication

• Medical Doctor (Medicine), University of Novi Sad, Yugoslavia, Serbia, 1986
• FRCPC Radiation Oncology, Royal College of Physicians of Canada, 1996

• Fellow of The Royal College of Physicians of Canada (Radiation Oncology), Vancouver Cancer Centre 1996-1997

BIOGRAPHIC SUMMARY ( Background, Academic Interests and Activities, Clinical Activities )

Dr. Keyes is a Clinical Professor in Radiation Oncology, University of British Columbia (UBC) in Vancouver, Prostate Brachytherapy Program past QA chair and head of the program 2006 – 2016. She is a Fellow (FABS) of American Brachytherapy Society (ABS), board member, and past education char for ABS and ASTRO Prostate Brachytherapy Workshops.  In 2017, she was awarded ABS Presidents Award, for outstanding contribution to ABS. Dr. Keyes is a Vice-Chair of the Royal College of Physicians and Surgeons of Canada AFC Diploma in Brachytherapy, a Brachytherapy AFC program director at UBC,  former Residency Training Program Director in Radiation Oncology at UBC, and past Royal College examiner.  She is an associate editor for Brachytherapy Journal.

She is a recipient of several UBC awards:  Mentorship Award (2018), Teaching Award (2017), CanMeds of Excellence Award (2104) and AD McKenzie UBC Department of Surgery Clinical Teaching Award 2017,  in 2019, nominated for Royal College of Physicians and Surgeons of Canada Mentorship Award. She is a CARO and BC Cancer wellness committee chair.

Dr. Keyes has been a keynote speaker at international conferences including ESTRO, ASTRO, ABS, CARO, ABG, and MD Anderson.   She is an author of over 90 peer-reviewed manuscripts and recipient of several peer review grants including a CIHR and Michael Smith Foundation grant for translational research in prostate cancer.


  1. Gomez-Iturriaga A, Keyes M, Martin J, Spratt DE. Should brachytherapy be added to external beam radiotherapy for prostate cancer? Lancet Oncol 2022 Jan;23(1):23-25.
  2. Raman S, Keyes M, Oh J, Rousseau E, Krauze A, Wilson D, et al. Patterns of prostate cancer recurrence after brachytherapy determined by PSMA PET/CT imaging. Int J Radiat Oncol Biol Phys 2022 Jan 2.
  3. King MT, Keyes M, Frank SJ, Crook JM, Butler WM, Rossi PJ, et al. Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement. Brachytherapy 2021 Nov-Dec;20(6):1114-1129.
  4. Frank SJ, Mourtada F, Crook J, Orio PF, Stock RG, Petereit DG, Keyes M et al. The American Brachytherapy Society prostate brachytherapy LDR/HDR simulation workshops: Hands-on, step-by-step training in the process of quality assurance. Brachytherapy 2020 Nov – Dec;19(6):787-793.
  5. Morton G, Taggar A, Keyes M, Crook J. Brachytherapy education and certification-A Canadian approach. Brachytherapy 2020 Nov – Dec;19(6):857-860.
  6. Crook JM, Tang C, Thames H, Blanchard P, Sanders J, Ciezki J, Keyes M et al. A biochemical definition of cure after brachytherapy for prostate cancer. Radiother Oncol 2020 Apr 27;149:64-69.
  7. Marban M, Crook J, Keyes M, Dubash R, Batchelar D. High-dose-rate brachytherapy for localized penile cancer: Evolution of a technique. Brachytherapy 2020 Mar – Apr;19(2):201-209.